C. Swanson

Patients Who Receive Androgen Deprivation Therapy Risk Adverse Cognitive Changes.

J. Yaxley, R. Gardiner, H. Green, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inactive free : total prostate specific antigen ratios in ejaculate from men with suspected and known prostate cancer, compared with young control men

R. Gardiner, J. Yaxley, K. deVoss, 2000, BJU international.

Altered cognitive function in men treated for prostate cancer with luteinizing hormone‐releasing hormone analogues and cyproterone acetate: a randomized controlled trial

R. Gardiner, J. Yaxley, H. Green, 2002, BJU international.

Quality of life compared during pharmacological treatments and clinical monitoring for non‐localized prostate cancer: a randomized controlled trial

R. Gardiner, J. Yaxley, H. Green, 2004, BJU international.

Re: The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.

R. Gardiner, J. Yaxley, H. Green, 2004, The Journal of urology.